Article
The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5).
Journal of the American College of Cardiology - 1 Feb 2005
Hodgkinson Kathy A, Parfrey Patrick S, Bassett Anne S, Kupprion Christine, Drenckhahn Jörg, Norman Mark W, Thierfelder Ludwig, Stuckless Susan N, Dicks Elizabeth L, McKenna William J, Connors Sean P
Abstract excerpt
OBJECTIVES: We sought to determine the impact of implantable cardioverter-defibrillator (ICD) therapy in patients with familial arrhythmogenic right ventricular cardiomyopathy (ARVC). BACKGROUND: Arrhythmogenic right ventricular cardiomyopathy is a cause of sudden cardiac death, which may be prevented by ICD. METHODS: We studied 11 families in which a 3p25 deoxyribonucleic acid (DNA) haplotype at locus ARVD5...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.